Arcturus Therapeutics Holdings paid its 5 named executives $4.8M in total in FY2025 (Dec). CEO Joseph E. Payne was paid $1.7M of that.
Pay$100 in the stock at the end of FY20 → $14
Pay of each named executive
Joseph E. PaynePresident and Chief Executive Officer, Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Andy SassineFormer Chief Financial Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Dr. Padmanabh ChivukulaChief Scientific Officer, Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Lance KurataChief Legal Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) | ||||||
| FY2021 (Dec) |
5 years
Joe RobertsInterim Principal Financial Officer and Accounting Officer; Controller
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 4 peers with pay on file was $11.7M. CEO pay of Arcturus Therapeutics Holdings for that year is not on file.
- 1PTC
- 2INSMED
- 3Novavax
- 4Vir Biotechnology
- 5Arcturus Therapeutics HoldingsThis companyNot disclosed
- 6ACADIANot disclosed
- 7BlueprintNot disclosed
- 8CoherusNot disclosed
- 9CollegiumNot disclosed
- 10CorceptNot disclosed
- 11DynavaxNot disclosed
- 12HeronNot disclosed
- 13IronwoodNot disclosed
- 14TravereNot disclosed
- 15UltragenyxNot disclosed
- 16VandaNot disclosed
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.